GSK Stock (GSK.re) Price Chart, Analysis, and Forecast

View the real-time GSK (GSK.re) stock quote and decide if you want to buy and when to sell. Find predictions, financials, the latest news and other information to help you with your stock investing.

$1,823.01
-0.46%
Followers
7
Annual change
15.75%
Buy
1,824.01
0.0117
Sell
1,823.01
Daily price range:
Low
1,791.99
High
1,824.01
Trade GSK now

All investing involves risk

GSK live price

Live Chart

Past performance is not a reliable indicator of future results.

Is GSK a good stock to buy?

The quantitative stock rating system created by TipRanks shows that GSK price is neutral. Its Smart Score¹ of 4 indicates GSK is a top stock to add to your watchlist.

4

Smart Score

Why is GSK stock price going up?

GSK

Bulls say

  • Acquisition Strategy

    The acquisition of efimosfermin is sound given that it expands GSK's hepatology portfolio, provides optionality to related diseases, and fits within GSK's BD strategy.

  • Pipeline Development

    Key launches and pipeline catalysts over the next 12 months should build confidence in GSK's £40B sales target by 2031, the majority of which is from on-market products.

  • Product Development

    The launch of depemokimab is another inflection point given the opportunity biologics have to further penetrate the respiratory market.

  • Product Launches

    Blenrep's U.S. PDUFA and commercial launches will be key factors in achieving GSK's target.

Why is GSK stock price going down?

GSK

Bears say

  • External Challenges

    Despite the uncertain external environment, GSK is confident in its ability to navigate challenges.

  • Sales Target Concerns

    GSK noted the majority (50%+) of its 2031 sales target of £40B is from products already on the market.

What is happening with
GSK stock price today?

  • The price of GSK today, as of October 1, 2026, was $1823.01. That's down -1.40% from the previous session's GSK closing price.

  • The GSK price is declining this week. Compared to last week, the rate of GSK is down -2.60%, and it's down -2.80% from one month ago.

  • The 52-week GSK price high is $2281.01, while the 52-week GSK price low is $1591.49.

  • Year to date, GSK price is up 13.90% from the beginning of the year and has had a return of 13.90% in the last 12 months.

What is the sentiment of GSK stock in October 2026?

The sentiment score², indicating how the crowd feels about GSK stock is POSITIVE. The sentiment signal³ observed at the start of the market session, offering insights into whether GSK stock price today is likely to increase, decrease, or remain steady, is BULLISH.

News Sentiment
Very Bullish
Very Bullish
Bullish: 100%Bearish: 0%
Blogger Opinion
Bullish
Bullish
Bullish: 76%Bearish: 24%
Investors Sentiment
Very Negative
Very Negative
Past 7d: -1%Past 30d: -3%

Table with the sentiment of GSK stock in October 2026

GSK stock analysis

Based on analysts giving ratings to GSK stock, the consensus⁴ is BUY. Hedge funds activity⁵ decreased in the last quarter, while Insider activity⁶ trend is N/A (N/A GSK shares)

GSK Technical Analysis

Trending downNegative
SMA
Trending up0.24
Momentum

Simple moving average: 20/200 days

Momentum: 12 month change

GSK Insider Activity

No data available

GSK Fundamentals

Trending up+28.0%
Return on equity
Trending up+1.0%
Asset Growth

Return on equity: last 12 months

Asset growth: 12 month change

Discover key GSK stock trends with NAGA Insights

What am I Missing?

  • Make informed decisions based on real-time data, expert analysis, and powerful research tools from TipRanks.

  • Access advanced GSK charting, technical analysis, and live market data from TradingView.

  • Get AI-powered GSK trade signals, in-depth market analysis, and technical strategy insights from Trading Central.

Sign up

All investing involves risk

Best Stocks Discover

GSK stock outlook 2026

Analysts forecast GSK stock price will fall in the next 12 months. Based on 2 Wall Street analysts offering GSK price predictions in the last 3 months, the average price target is $65.00.

The highest GSK stock forecast is $70.00, while the lowest is $60.00. The average GSK price target represents a 34.94% change from the actual price of $1823.01.

GSK stock price prediction⁷

  • Highest price target$70.00
  • Average price target$65.00
  • Lowest price target$60.00

GSK stock forecast⁸

  • Buy50.00%
  • Hold50.00%
  • Sell0.00%

Overview of stock forecast and price predictions 2026. Analyst price targets and consensus are estimates only and do not constitute guarantees of future outcomes.

Investing in GSK stock

There are two ways to invest in GSK stock: trading GSK stock through derivatives like CFDs or buying shares of GSK stock outright. With NAGA.com, you can do both and more.


Buy GSK shares of stock if you want to hold them for a long time. You commit the full value of the GSK shares outright and profit only if they increase in price.


Trade GSK if you want more flexibility — say you want to speculate on its price movements in both directions. With CFDs, you can open a buy position (go long) if you think GSK stock’s price will rise, or you can open a sell position (go short) if you believe the GSK stock’s price will fall.


You won’t need to commit to the full value of the position. But bear in mind that leverage can increase both your profits and losses.

How to invest

How to trade GSK with CFDs?

  • If you want to speculate on GSK price, search for GSK CFD. Then click on the "GSK" symbol to view the chart and other insights before placing your trade. Also, review "GSK" contract specification to be aware of all the GSK CFD trading conditions.

How to buy GSK stock?

  • If you want to buy GSK shares outright to hold them for a long time, search for GSK stock with ownership (Real Stocks). Then click on the "GSK" symbol to view the chart and other insights before placing your trade. Also, review "GSK" contract specification to be aware of all the GSK stock buying conditions.

trading conditions:

Platform
MT5
Ticker#GSK.re
Volume step
Lot value
Minimum trade size
Maximum trade size
Commission0.00%
Monthly price change (%)-0.46%
Annual price change (%)15.75%
Digits
Tick value0
Trading Hours & Fees
Get Started

All investing involves risk

GSK company presentation

GSK

Gsk

Real Stocks

-0.46%

$1,824.01
$1,823.01

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.

Latest GSK stock news

Discover the latest news that can influence GSK’s earnings sentiment and GSK forecast and price predictions.

Neutral
Wave Life announces GSK’s selection of siRNA program to transition to GSK
30/09/2026/07:40
Read more
Neutral
GSK vs. SNY: Which Europe-Based Pharma Stock Has More Potential?
29/09/2026/07:37
Read more
Positive
GSK retains ‘buy’ rating at Jefferies as B7H3 cancer programme seen as underappreciated
29/09/2026/07:30
Read more

FAQs about GSK trading

The price of GSK stock today, as of October 1, 2026, was 1823.01. That's down -1.40% from the previous session's GSK closing price.

IMPORTANT NOTICE: The content presented in the instrument page is only for informational, educational and support purposes. The material presented, including analyses, sentiment, consensus, prices, opinions or other content, is not an investment recommendation or information that recommends or suggests an investment strategy, nor is it included in the scope of investment advice. NAGA will not accept liability for any loss or damage, including but not limited to any loss of profits, that may arise directly or indirectly from the use of or reliance on the information contained in this page. NAGA is not responsible for the actions or omissions of the client, especially for the acquisition or disposal of financial instruments, made based on the information contained in this page. Past performance is not necessarily indicative of future results, and anyone acting on this information does so at their own risk. ¹ ⁵ ⁶ The Smart Score is a proprietary quantitative stock scoring system created by TipRanks. It assigns stocks a score from one to ten, based on 8 market key factors. The lowest score is 1, and the highest is 10. Stocks with a score of 8, 9, or 10 are considered Outperform, and with a score of 1, 2, or 3 are considered Underperform. The score is data-driven and does not involve any human intervention. The contributing market factors are Wall Street analyst ratings, Corporate insider transactions, Financial blogger opinions, Individual investor sentiment, Hedge fund manager activity, News sentiment, Technicals and Fundamentals. This information is provided for indicative purposes only and should not be interpreted as investment advice or a recommendation to trade. ⁴ ⁷ ⁸ TipRanks’ consensus ratings provide an aggregated view of expectations and consensus on a particular stock from a wide range of global analyst opinions. They’re then condensed into a single indicator, which can help you make investment decisions based on expert analysis. TipRanks’ 12-month forecast is a consensus price target derived from Wall Street analysts’ projections made over the past three months. It forecasts the potential high, low, and average share price for a stock one year from now, along with the average expected upside or downside percentage. ² ³ The sentiment signal and sentiment score are provided by Trading Central. Sentiment insights and market views are based on available data and do not guarantee future performance.

Need Help? Visit our Help Section
Download NAGA Trader

Copyright © 2026 – All rights reserved.

NAGA is a trademark of The NAGA Group AG, a German based FinTech company publicly listed on the Frankfurt Stock Exchange | WKN: A41YCM | ISIN: DE000A41YCM0.

Privacy Policy | Cookie Policy | Terms and Conditions | Terms of Use

The website is operated by NAGA Markets Europe LTD which is authorised and regulated by the Cyprus Securities and Exchange Commission (CySEC) under licence No. 204/13. The registered address of NAGA Markets Europe LTD is Agias Zonis 11, Limassol 3027, Cyprus. NAGA Markets Europe LTD is also registered with the Romanian Financial Supervisory Authority (“ASF”) with registration no. PJM01SFIM/400019.

RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage of retail investor accounts lose money when trading CFDs with this provider.You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Trading with NAGA Trader by following and/or copying or replicating the trades of other traders involves high levels of risks, even when following and/or copying or replicating the top-performing traders. Such risks include the risk that you may be following/copying the trading decisions of possibly inexperienced/unprofessional traders, or traders whose ultimate purpose or intention, or financial status may differ from yours. Before making an investment decision, you should rely on your own assessment of the person making the trading decisions and the terms of all the legal documentation.

Other group entities: JME Financial Services (Pty) Ltd operates naga.com/za an authorised Financial Services Provider and is regulated by the Financial Sector Conduct Authority in South Africa under license no. 37166.

Key Way Markets Ltd operates naga.com/ae and is authorized and regulated by the Abu Dhabi Global Market (ADGM) Financial Services Regulatory Authority (license no. 190005).

NAGA Capital Ltd operates naga.com/en and is authorised and regulated by the Seychelles Financial Services Authority (FSA) (license no. SD026).

Restricted regions: NAGA Markets Europe LTD offers services to residents within the European Economic Area, excluding Belgium. NAGA Markets Europe LTD does not provide investment and ancillary services in the territories of third countries.

Affiliate programs are not permitted in Spain for the investment service commercialisation or client acquisitions by unauthorised third parties.

Los programas de afiliados no están permitidos en España para la comercialización de servicios de inversión y captación de clientes por parte de terceros no autorizados.

RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 77.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.